112 related articles for article (PubMed ID: 7324908)
1. Immunoreactive trypsin, chymotrypsin, and pancreatic secretory trypsin inhibitor in cord blood from infants with cystic fibrosis.
Borgström A; Sveger T; Lindberg T; Kullander S; Svanberg L
Acta Paediatr Scand; 1981 Sep; 70(5):619-21. PubMed ID: 7324908
[No Abstract] [Full Text] [Related]
2. Varying occurrence of gastroduodenal immunoreactive pancreatic secretory trypsin inhibitor.
Bohe M; Lindström CG; Ohlsson K
J Clin Pathol; 1987 Nov; 40(11):1345-8. PubMed ID: 3320096
[TBL] [Abstract][Full Text] [Related]
3. Protease inhibitor and defective proteolysis in cystic fibrosis.
Hsieh MC; Berry HK
Dig Dis Sci; 1988 Mar; 33(3):282-8. PubMed ID: 2449319
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of pancreatic secretory trypsin inhibitor in fetal and adult pancreatic and extrapancreatic tissues.
Fukayama M; Hayashi Y; Koike M; Ogawa M; Kosaki G
J Histochem Cytochem; 1986 Feb; 34(2):227-35. PubMed ID: 3511141
[TBL] [Abstract][Full Text] [Related]
5. Stool trypsin and chymotrypsin. Value in the diagnosis of pancreatic insufficiency in cystic fibrosis.
Barbero GJ; Sibinga MS; Marino JM; Seibel R
Am J Dis Child; 1966 Dec; 112(6):536-40. PubMed ID: 5928817
[No Abstract] [Full Text] [Related]
6. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
J Mol Biol; 1987 Nov; 198(1):129-32. PubMed ID: 3430603
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of monoclonal antibodies against bovine pancreatic trypsin inhibitor.
Marini S; Fiorucci L; Fioretti E; Giardina B; Ascoli F
Biol Chem Hoppe Seyler; 1989 Oct; 370(10):1085-92. PubMed ID: 2610927
[TBL] [Abstract][Full Text] [Related]
8. Sensitive trypsin assay for dried-blood specimens as a screening procedure for early detection of cystic fibrosis.
King DN; Heeley AF; Walsh MP; Kuzemko JA
Lancet; 1979 Dec; 2(8154):1217-9. PubMed ID: 92625
[TBL] [Abstract][Full Text] [Related]
9. Effects of proteinase--inhibitor binding on accessibility of exposed tyrosines. A photochemically induced dynamic nuclear polarization study of bovine pancreatic trypsin inhibitor complexes with trypsin, chymotrypsin, and their zymogens.
Muszkat KA; Weinstein S; Khait I; Vered M
Biochemistry; 1982 Aug; 21(16):3775-9. PubMed ID: 7138805
[No Abstract] [Full Text] [Related]
10. Serum-immunoreactive-trypsin concentrations in cystic fibrosis.
Dandona P; Hodson M; Bell J; Ramdial L; Batten JC
Lancet; 1979 May; 1(8124):1032. PubMed ID: 86747
[No Abstract] [Full Text] [Related]
11. Human leukocyte elastase inhibitors: designed variants of human pancreatic secretory trypsin inhibitor (hPSTI).
Collins J; Szardenings M; Maywald F; Blöcker H; Frank R; Hecht HJ; Vasel B; Schomburg D; Fink E; Fritz H
Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():29-36. PubMed ID: 2400589
[TBL] [Abstract][Full Text] [Related]
12. Titrimetric measurements of fecal trypsin and chymotrypsin in cystic fibrosis with pancreatic exocrine insufficiency.
Dyck WP
Am J Dig Dis; 1967 Mar; 12(3):310-7. PubMed ID: 6019224
[No Abstract] [Full Text] [Related]
13. Immunoreactive trypsin in blood from foetuses and preterm infants.
Borgström A; Lindberg T; Sveger T; Kullander S; Svanberg L
Acta Paediatr Scand; 1982 Sep; 71(5):849-50. PubMed ID: 7180458
[No Abstract] [Full Text] [Related]
14. Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases.
Matsuda K; Ogawa M; Murata A; Kitahara T; Kosaki G
Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):301-5. PubMed ID: 6878869
[TBL] [Abstract][Full Text] [Related]
15. Production of specific monoclonal antibodies against the active sites of human pancreatic secretory trypsin inhibitor variants by in vitro immunization with synthetic peptides.
Böldicke T; Kindt S; Maywald F; Fitzlaff G; Böcher M; Frank R; Collins J
Eur J Biochem; 1988 Aug; 175(2):259-64. PubMed ID: 3402453
[TBL] [Abstract][Full Text] [Related]
16. Serum trypsinlike immunoreactivity in cystic fibrosis. An aid in assessing progressive involvement of the pancreas.
Masoero G; Andriulli A; Santini B; Benitti V; Ansaldi N; Verme G
Am J Dis Child; 1983 Feb; 137(2):167-70. PubMed ID: 6849303
[TBL] [Abstract][Full Text] [Related]
17. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step.
Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D
J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic secretory trypsin inhibitor from human amniotic fluid and fetal and neonatal urine: concentrations and physicochemical characterization.
Kolho KL; Huhtala ML; Jalanko H; Rauramo I; Stenman UH
Clin Chim Acta; 1986 Apr; 156(2):123-9. PubMed ID: 3085985
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactive pancreatic secretory trypsin inhibitor in sera from patients with acute ulcerative colitis.
Bohe M
Res Exp Med (Berl); 1987; 187(1):55-8. PubMed ID: 3575884
[TBL] [Abstract][Full Text] [Related]
20. A possible evolutionary relationship between plant trypsin inhibitor, alpha-amylase inhibitor, and mammalian pancreatic secretory trypsin inhibitor (Kazal).
Odani S; Koide T; Ono T
J Biochem; 1983 Jun; 93(6):1701-4. PubMed ID: 6885745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
